Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof

Christian Lanctot (Inventor), Pierre Moffatt (Inventor), Gethin Thomas (Inventor)

    Research output: Patent

    Abstract

    A method of using an osteocrin (Ostn) or a NPR-C specific Ostn peptide derivative for increasing osteogenesis in a mammal comprising administering a therapeutically effective amount of said Ostn or NPR-C specific Ostn peptide derivative to the mammal.
    Original languageUndefined/Unknown
    Patent numberUS7470668 B2
    Priority date23/08/05
    Publication statusPublished - 30 Dec 2008

    Cite this